
Keith D. Walker
Supervisory Patent Examiner (ID: 18805, Phone: (571)272-3458 , Office: P/1735 )
| Most Active Art Unit | 1735 |
| Art Unit(s) | 1745, 1726, 1795, 1735 |
| Total Applications | 565 |
| Issued Applications | 152 |
| Pending Applications | 54 |
| Abandoned Applications | 362 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9293905
[patent_doc_number] => 20140037538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'N-ALKYL 2-(DISUBSTITUTED)ALKYNYLADENOSINE-5-URONAMIDES AS A2A AGONISTS'
[patent_app_type] => utility
[patent_app_number] => 13/956111
[patent_app_country] => US
[patent_app_date] => 2013-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14722
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13956111
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/956111 | N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists | Jul 30, 2013 | Issued |
Array
(
[id] => 10414056
[patent_doc_number] => 20150299066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-22
[patent_title] => 'RADIOFLUORINATION METHOD'
[patent_app_type] => utility
[patent_app_number] => 14/417749
[patent_app_country] => US
[patent_app_date] => 2013-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7480
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14417749
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/417749 | Radiofluorination method | Jul 29, 2013 | Issued |
Array
(
[id] => 10272747
[patent_doc_number] => 20150157744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-11
[patent_title] => 'TREATMENT OF MENINGIOMAS USING PHENYLBENZOTHIAZOLE, STILBENE, BIPHENYLALKYNE, OR PYRIDINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/411577
[patent_app_country] => US
[patent_app_date] => 2013-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18697
[patent_no_of_claims] => 85
[patent_no_of_ind_claims] => 43
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14411577
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/411577 | TREATMENT OF MENINGIOMAS USING PHENYLBENZOTHIAZOLE, STILBENE, BIPHENYLALKYNE, OR PYRIDINE DERIVATIVES | Jun 25, 2013 | Abandoned |
Array
(
[id] => 9262065
[patent_doc_number] => 20130343994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'Cholinesterase Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/926661
[patent_app_country] => US
[patent_app_date] => 2013-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 17936
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13926661
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/926661 | Cholinesterase Inhibitors | Jun 24, 2013 | Abandoned |
Array
(
[id] => 9107037
[patent_doc_number] => 20130280169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'CENTRAL NERVOUS SYSTEM TISSUE-LABELING COMPOSITION, METHOD FOR LABELING CENTRAL NERVOUS SYSTEM TISSUE, AND SCREENING METHOD USING CENTRAL NERVOUS SYSTEM TISSUE-LABELING COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 13/921945
[patent_app_country] => US
[patent_app_date] => 2013-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 11286
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13921945
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/921945 | CENTRAL NERVOUS SYSTEM TISSUE-LABELING COMPOSITION, METHOD FOR LABELING CENTRAL NERVOUS SYSTEM TISSUE, AND SCREENING METHOD USING CENTRAL NERVOUS SYSTEM TISSUE-LABELING COMPOSITION | Jun 18, 2013 | Abandoned |
Array
(
[id] => 10540978
[patent_doc_number] => 09266084
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-02-23
[patent_title] => 'Automatic synthesizer apparatus for producing radiopharmaceutical tumor imaging agent Gallium-68-DOTATATE and method thereof'
[patent_app_type] => utility
[patent_app_number] => 13/916599
[patent_app_country] => US
[patent_app_date] => 2013-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3131
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 215
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13916599
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/916599 | Automatic synthesizer apparatus for producing radiopharmaceutical tumor imaging agent Gallium-68-DOTATATE and method thereof | Jun 12, 2013 | Issued |
Array
(
[id] => 10254905
[patent_doc_number] => 20150139902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-21
[patent_title] => 'PURIFICATION OF [18F] - FLUCICLATIDE'
[patent_app_type] => utility
[patent_app_number] => 14/401255
[patent_app_country] => US
[patent_app_date] => 2013-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8189
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14401255
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/401255 | PURIFICATION OF [18F] - FLUCICLATIDE | May 22, 2013 | Abandoned |
Array
(
[id] => 9204867
[patent_doc_number] => 20140004044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'USE OF FLUORINATED DERIVATIVES OF 4-AMINOPYRIDINE IN THERAPEUTICS AND MEDICAL IMAGING'
[patent_app_type] => utility
[patent_app_number] => 13/897035
[patent_app_country] => US
[patent_app_date] => 2013-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 24057
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13897035
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/897035 | USE OF FLUORINATED DERIVATIVES OF 4-AMINOPYRIDINE IN THERAPEUTICS AND MEDICAL IMAGING | May 16, 2013 | Abandoned |
Array
(
[id] => 10254904
[patent_doc_number] => 20150139901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-21
[patent_title] => 'Radioactive Rhodium Complexes, Preparation Methods and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/399305
[patent_app_country] => US
[patent_app_date] => 2013-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8507
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14399305
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/399305 | Radioactive Rhodium Complexes, Preparation Methods and Uses Thereof | May 13, 2013 | Abandoned |
Array
(
[id] => 9147724
[patent_doc_number] => 20130302247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-14
[patent_title] => 'SYNTHESIS OF FLUOROARACHIDONIC ACID AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/890884
[patent_app_country] => US
[patent_app_date] => 2013-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12125
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13890884
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/890884 | SYNTHESIS OF FLUOROARACHIDONIC ACID AND METHODS OF USE THEREOF | May 8, 2013 | Abandoned |
Array
(
[id] => 10248781
[patent_doc_number] => 20150133777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-14
[patent_title] => 'POSITRON EMISSION TOMOGRAPHY PROBE TO MONITOR SELECTED SUGAR METABOLISM IN VIVO'
[patent_app_type] => utility
[patent_app_number] => 14/399701
[patent_app_country] => US
[patent_app_date] => 2013-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 9633
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14399701
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/399701 | Positron emission tomography probe to monitor selected sugar metabolism in vivo | May 8, 2013 | Issued |
Array
(
[id] => 10240395
[patent_doc_number] => 20150125390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-07
[patent_title] => '18F-LABELLED FOLATE/ANTIFOLATE ANALOGUES'
[patent_app_type] => utility
[patent_app_number] => 14/399688
[patent_app_country] => US
[patent_app_date] => 2013-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 17633
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14399688
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/399688 | 18F-labelled folate/antifolate analogues | May 7, 2013 | Issued |
Array
(
[id] => 9173840
[patent_doc_number] => 20130315825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'TRICYCLIC HETEROAROMATIC COMPOUNDS AS ALPHA-SYNUCLEIN LIGANDS'
[patent_app_type] => utility
[patent_app_number] => 13/887171
[patent_app_country] => US
[patent_app_date] => 2013-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 29599
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13887171
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/887171 | TRICYCLIC HETEROAROMATIC COMPOUNDS AS ALPHA-SYNUCLEIN LIGANDS | May 2, 2013 | Abandoned |
Array
(
[id] => 9369762
[patent_doc_number] => 20140079635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-20
[patent_title] => 'MOLECULAR PROBES FOR DETECTING LIPID COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 13/872733
[patent_app_country] => US
[patent_app_date] => 2013-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 17905
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13872733
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/872733 | MOLECULAR PROBES FOR DETECTING LIPID COMPOSITION | Apr 28, 2013 | Abandoned |
Array
(
[id] => 9930808
[patent_doc_number] => 20150079000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-19
[patent_title] => 'Labelled Quinoxaline Derivatives as Multimodal Radiopharmaceuticals and Their Precursors'
[patent_app_type] => utility
[patent_app_number] => 14/396879
[patent_app_country] => US
[patent_app_date] => 2013-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 23101
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14396879
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/396879 | Labelled Quinoxaline Derivatives as Multimodal Radiopharmaceuticals and Their Precursors | Apr 18, 2013 | Abandoned |
Array
(
[id] => 15538435
[patent_doc_number] => 10568978
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-25
[patent_title] => Radiopharmaceutical synthesis methods
[patent_app_type] => utility
[patent_app_number] => 14/390425
[patent_app_country] => US
[patent_app_date] => 2013-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 2677
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14390425
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/390425 | Radiopharmaceutical synthesis methods | Apr 9, 2013 | Issued |
Array
(
[id] => 9908910
[patent_doc_number] => 20150064111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-05
[patent_title] => 'NOVEL TARGETING AGENTS FOR DIAGNOSTIC AND THERAPEUTIC INDICATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/390031
[patent_app_country] => US
[patent_app_date] => 2013-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16463
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14390031
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/390031 | NOVEL TARGETING AGENTS FOR DIAGNOSTIC AND THERAPEUTIC INDICATIONS | Apr 2, 2013 | Abandoned |
Array
(
[id] => 8989194
[patent_doc_number] => 20130216475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-22
[patent_title] => 'METHODS AND COMPOSITIONS FOR PROTEIN LABELLING'
[patent_app_type] => utility
[patent_app_number] => 13/855126
[patent_app_country] => US
[patent_app_date] => 2013-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16945
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13855126
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/855126 | Methods and compositions for protein labelling | Apr 1, 2013 | Issued |
Array
(
[id] => 8990606
[patent_doc_number] => 20130217887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-22
[patent_title] => 'Compounds With Matrix-Metalloproteinase Inhibitory Activity and Imaging Agents Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/849646
[patent_app_country] => US
[patent_app_date] => 2013-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9393
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13849646
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/849646 | Compounds with matrix-metalloproteinase inhibitory activity and imaging agents thereof | Mar 24, 2013 | Issued |
Array
(
[id] => 9648044
[patent_doc_number] => 08802053
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-12
[patent_title] => 'Radio-methyl vorozole and methods for making and using the same'
[patent_app_type] => utility
[patent_app_number] => 13/847136
[patent_app_country] => US
[patent_app_date] => 2013-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8534
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13847136
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/847136 | Radio-methyl vorozole and methods for making and using the same | Mar 18, 2013 | Issued |